Combining PSMA-PET metrics and circulating tumor cell RNA sequencing to predict LuPSMA response.Kendra D. Marr, Joshua M. Lang, Marina N. Sharifi et al.|Journal of Clinical Oncology|2026Cited by 0
Efficacy and safety of belzutifan in patients with metastatic clear cell renal cell carcinoma (mccRCC): Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).Chris Labaki, Rana R. McKay, Razane El Hajj Chehade et al.|Journal of Clinical Oncology|2026Cited by 0